CMP-001 for Relapsed and Refractory Lymphoma
Clinical trial NCT03983668 · TERMINATED
Trial details
- NCT number
- NCT03983668
- Sponsor
- Umar Farooq
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2024-08-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.